US 12,491,109 B2
Hyperthermic conditioning capsule
Steven J. Daffer, Edina, MN (US)
Assigned to VISIBELLE DERMA INSTITUTE, INC., Bloomington, MN (US)
Filed by Visibelle Derma Institute, Inc., Bloomington, MN (US)
Filed on Mar. 25, 2022, as Appl. No. 17/704,645.
Application 17/704,645 is a continuation of application No. 16/010,927, filed on Jun. 18, 2018, granted, now 11,311,410.
Claims priority of provisional application 62/521,802, filed on Jun. 19, 2017.
Prior Publication US 2022/0218515 A1, Jul. 14, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61F 7/00 (2006.01); A61M 19/00 (2006.01); A61M 21/00 (2006.01); A61N 5/06 (2006.01); A63B 21/00 (2006.01); A63B 21/002 (2006.01); A63B 21/055 (2006.01); A63B 21/062 (2006.01); A63B 21/065 (2006.01); A63B 22/04 (2006.01); A63B 22/06 (2006.01); A63B 71/04 (2006.01); A61M 11/00 (2006.01); A61N 5/00 (2006.01)
CPC A61F 7/0053 (2013.01) [A61F 7/0085 (2013.01); A61M 19/00 (2013.01); A61M 21/0094 (2013.01); A61N 5/0625 (2013.01); A63B 21/0023 (2013.01); A63B 21/0552 (2013.01); A63B 21/0628 (2015.10); A63B 21/065 (2013.01); A63B 21/4013 (2015.10); A63B 21/4021 (2015.10); A63B 21/4034 (2015.10); A63B 21/4035 (2015.10); A63B 22/04 (2013.01); A63B 22/0605 (2013.01); A63B 71/04 (2013.01); A61F 2007/0052 (2013.01); A61F 2007/0055 (2013.01); A61F 2007/0057 (2013.01); A61F 2007/0064 (2013.01); A61F 2007/0086 (2013.01); A61F 2007/0093 (2013.01); A61F 2007/0096 (2013.01); A61M 11/00 (2013.01); A61M 2021/0027 (2013.01); A61M 2021/0044 (2013.01); A61M 2021/0055 (2013.01); A61M 2021/0066 (2013.01); A61M 2021/0072 (2013.01); A61M 2202/0208 (2013.01); A61M 2205/051 (2013.01); A61M 2205/056 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3606 (2013.01); A61M 2205/3646 (2013.01); A61M 2205/368 (2013.01); A61M 2230/06 (2013.01); A61M 2230/205 (2013.01); A61M 2230/30 (2013.01); A61M 2230/50 (2013.01); A61N 2005/007 (2013.01); A61N 2005/0637 (2013.01); A61N 2005/0652 (2013.01); A61N 2005/0659 (2013.01); A63B 2208/0252 (2013.01); A63B 2209/00 (2013.01); A63B 2213/002 (2013.01); A63B 2213/005 (2013.01)] 26 Claims
OG exemplary drawing
 
1. A method of conditioning comprising:
providing a capsule comprising:
a base supporting a bed; and
a top hingedly connected to the base;
after a human being at least partially lies on the bed, positioning the top into a closed position to provide a first substantially enclosed space for a body of the human being and a second space for a head of the human being;
monitoring at least one biometric variable of the human being as the human being exercises;
controlling an environmental temperature of the first substantially enclosed space with one or more heating elements to elevate the environmental temperature within the enclosed space to a temperature which elevates a body temperature of the human being while exercising to provide hyperthermic conditioning within the first substantially enclosed space; and
directing cooled air towards the body of the human being after hyperthermic conditioning within the first substantially enclosed space to reduce the body temperature of the human being.